Naproxen Sodium NDC 62207-327

Product information

Brand name (proprietary)

Naproxen Sodium

Generic name (nonproprietary)

naproxen sodium

Active ingredients

Naproxen sodium — 220 mg/1

Dosage form

Tablet

Route

Oral

Labeler

Granules India Ltd

Product type

Over-the-counter drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 091353

Marketing start

Jul 16, 2021

Listing expires

Dec 31, 2026

Other FDA classes

Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)

Identifiers

Product ID 62207-327_f4026a0a-c9cd-3850-e053-2995a90a459cSPL ID f4026a0a-c9cd-3850-e053-2995a90a459cSPL set ID 95ba1722-60ed-4a83-9f26-50c4de8cf180RxCUI 849574UNII 9TN87S3A3C

Pharmacologic class

Nonsteroidal Anti-inflammatory Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462207032741 followed by a unit qualifier and the quantity Copy

Package 62207-0327-41. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Label details couldn’t be retrieved right now. Open the label on DailyMed.

Other NDCs under ANDA 091353

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.